| Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled … JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... MedRxiv, 2020 | 177 | 2020 |
| Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... The Lancet Rheumatology 2 (11), e698-e711, 2020 | 126 | 2020 |
| Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to … E Burn, CJ Edwards, DW Murray, A Silman, C Cooper, NK Arden, ... BMJ open 8 (1), e019146, 2018 | 124 | 2018 |
| Ten-year patient-reported outcomes following total and minimally invasive unicompartmental knee arthroplasty: a propensity score-matched cohort analysis E Burn, MT Sanchez-Santos, HG Pandit, TW Hamilton, AD Liddle, ... Knee Surgery, Sports Traumatology, Arthroscopy 26, 1455-1464, 2018 | 88 | 2018 |
| Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahão, ... Nature communications 11 (1), 5009, 2020 | 87 | 2020 |
| Cost-effectiveness of unicompartmental compared with total knee replacement: a population-based study using data from the National Joint Registry for England and Wales E Burn, AD Liddle, TW Hamilton, A Judge, HG Pandit, DW Murray, ... BMJ open 8 (4), e020977, 2018 | 86 | 2018 |
| Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis X Li, B Raventós, E Roel, A Pistillo, E Martinez-Hernandez, A Delmestri, ... bmj 376, 2022 | 82 | 2022 |
| A cost‐effectiveness analysis of optimal care for diabetic foot ulcers in Australia Q Cheng, PA Lazzarini, M Gibb, PH Derhy, EM Kinnear, E Burn, N Graves, ... International wound journal 14 (4), 616-628, 2017 | 79 | 2017 |
| Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study E Burn, T Duarte-Salles, S Fernandez-Bertolin, C Reyes, K Kostka, ... The Lancet Infectious Diseases 22 (8), 1142-1152, 2022 | 75 | 2022 |
| The natural history of symptomatic COVID-19 during the first wave in Catalonia E Burn, C Tebé, S Fernandez-Bertolin, M Aragon, M Recalde, E Roel, ... Nature communications 12 (1), 777, 2021 | 75 | 2021 |
| Improved wound management at lower cost: a sensible goal for Australia RE Norman, M Gibb, A Dyer, J Prentice, S Yelland, Q Cheng, ... International wound journal 13 (3), 303-316, 2016 | 69 | 2016 |
| Data resource profile: the information system for research in primary care (SIDIAP) M Recalde, C Rodríguez, E Burn, M Far, D García, J Carrere-Molina, ... International Journal of Epidemiology 51 (6), e324-e336, 2022 | 63 | 2022 |
| Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study A Prats-Uribe, AG Sena, LYH Lai, H Alghoul, O Alser, TM Alshammari, ... bmj 373, 2021 | 63 | 2021 |
| Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events E Burn, S Nghiem, S Jan, J Redfern, A Rodgers, A Thiagalingam, ... Heart 103 (12), 893-894, 2017 | 59 | 2017 |
| A cost-effectiveness modelling study of strategies to reduce risk of infection following primary hip replacement based on a systematic review N Graves, C Wloch, J Wilson, A Barnett, A Sutton, N Cooper, K Merollini, ... Health Technology Assessment, 2016 | 59 | 2016 |
| Thirty-day outcomes of children and adolescents with COVID-19: an international experience T Duarte-Salles, D Vizcaya, A Pistillo, P Casajust, AG Sena, LYH Lai, ... Pediatrics 148 (3), 2021 | 52 | 2021 |
| Common problems, common data model solutions: evidence generation for health technology assessment S Kent, E Burn, D Dawoud, P Jonsson, JT Østby, N Hughes, P Rijnbeek, ... Pharmacoeconomics 39 (3), 275-285, 2021 | 52 | 2021 |
| Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network RD Williams, AF Markus, C Yang, T Duarte-Salles, SL DuVall, T Falconer, ... BMC Medical Research Methodology 22 (1), 35, 2022 | 45 | 2022 |
| Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient … E Burn, X Li, K Kostka, HM Stewart, C Reich, S Seager, T Duarte‐Salles, ... Pharmacoepidemiology and Drug Safety 31 (5), 495-510, 2022 | 41 | 2022 |
| Lifetime risk of knee and hip replacement following a GP diagnosis of osteoarthritis: a real-world cohort study E Burn, DW Murray, GA Hawker, R Pinedo-Villanueva, D Prieto-Alhambra Osteoarthritis and cartilage 27 (11), 1627-1635, 2019 | 38 | 2019 |
